Kevin Robert Lind - 13 Nov 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role: CEO, Director
Signature: /s/ Andrew J. Cronauer, Attorney-In-Fact
Issuer symbol: LBPH
Transactions as of: 13 Nov 2024
Net transactions value: +$40,002
Form type: 4
Filing time: 13 Nov 2024, 20:48:14 UTC
Previous filing: 29 Oct 2024
Next filing: 02 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LBPH	Common Stock	Options Exercise	$40,002	+12,808	+3%	$3.12	443,740	13 Nov 2024	Direct	F1
transaction	LBPH	Common Stock	Gift	$0	-80,000	-18%	$0.000000	363,740	13 Nov 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LBPH	Stock Option (Right to Buy)	Options Exercise	$0	-12,808	-4.8%	$0.000000	255,377	13 Nov 2024	Common Stock	12,808	$3.12	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a cash exercise of vested stock options without a subsequent sale of the underlying shares of common stock.
F2	Represents shares of common stock gifted to a donor-advised trust.
F3	The shares subject to the stock option vested and became exercisable in 24 equal monthly installments commencing November 27, 2022.